ACADEMIC FRONTIERS
学术前沿
Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects.
上一篇：Tolerability and efficacy of pegylated consensus interferonα in the treatment of chronic hepatitis C
下一篇：Tolerability, pharmacokinetics and antiviral activity of rHSA/IFNα2a for the treatment of chronic hepatitis B infection
返回列表
